Skip to main content
NoticePayment processing is currently down, so we are not taking new orders right now. Thank you for your patience.
For laboratory research use only. Not for human or veterinary use.
Free UPS Ground on 3+ vials · same business day by 2 PM ET
BPC-157 + TB-500Preclinical

Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice

Philp D, Badamchian M, Scheremeta B, et al. · Wound Repair Regen · 2003
PMID: 12581423 · DOI: 10.1046/j.1524-475x.2003.11106.x
Summary

Preclinical full-thickness dermal wound study in db/db diabetic and aged mice characterizing thymosin beta 4 and a synthetic actin-binding domain peptide. Endpoints: keratinocyte migration, wound contracture, collagen deposition.

Read the full citation on PubMed

Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.

Compounds referenced in this study
  • TB-500 (Long Chain)
    Synthetic acetylated thymosin-β4 (1-43) analog. Studied in tissue-regeneration research.
    View product →
Guides covering this compound
More BPC-157 + TB-500 citations
Browse the catalog